Screener
Denali Therapeutics Inc. DNLI Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Denali Therapeutics Inc.’s reported figures.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
FAQ
- What is Denali Therapeutics Inc.'s invested capital?
- Denali Therapeutics Inc. (DNLI) reported invested capital of $668.23M in Q2 2026.
- How has Denali Therapeutics Inc.'s invested capital changed year-over-year?
- Denali Therapeutics Inc.'s invested capital decreased by 28.2% year-over-year, from $930.71M to $668.23M.
- What is the long-term trend for Denali Therapeutics Inc.'s invested capital?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s invested capital has grown at a 3.6% compound annual growth rate (CAGR), from $710.75M to $847.7M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Denali Therapeutics Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude